Imagine a world where you can access CBD products that are safe, effective, and of the highest quality. Well, that world just got one step closer with the exciting partnership between Panacea Life Sciences, Inc. and Chanelle McCoy Health. As a European CBD market leader, Chanelle McCoy Health brings with it a wealth of experience and success, backed by clinical studies and governmental authorities. Together, these two companies are joining forces to launch an Ultra Pure CBD product in the US, targeting consumers who are seeking THC-free options. With a commitment to science-based CBD products, this partnership aims to become the go-to provider for those looking for a reliable source of CBD. And that’s not all–their sights are set on global expansion, tapping into the ever-growing market for CBD around the world. Plus, as an added bonus, Panacea has recently made its entrance into the Brazilian cannabis market through a partnership with MyPharma2Go. Get ready for a new era of CBD products that can truly meet your needs, thanks to this exciting collaboration.
Panacea Life Sciences, Inc. partners with Chanelle McCoy Health for its US launch
Panacea Life Sciences, Inc., a leading CBD company, has exciting news to share: a partnership with Chanelle McCoy Health for its US launch. This collaboration aims to provide the US market with safer, higher quality, and more effective CBD products. With Chanelle McCoy Health’s CBD brand, Pureis®, already successful in the UK market and backed by clinical studies and governmental authorities, this partnership brings together two companies that are aligned in their shared values of providing safe, effective, and high-quality products to consumers.
Providing safer, higher quality, and more effective CBD products
The primary focus of this partnership is to provide consumers with CBD products that are safer, higher in quality, and more effective. Both Panacea Life Sciences and Chanelle McCoy Health recognize the importance of ensuring the safety and efficacy of CBD products, and through their combined efforts, they aim to set a new standard in the industry.
The premium provider of science-based CBD products
As part of their alliance, Panacea Life Sciences and Chanelle McCoy Health aspire to become the leading provider of science-based CBD products in the US. By leveraging their expertise and resources, they aim to develop innovative CBD solutions that are rooted in scientific research and offer a range of benefits to consumers.
A specific target market for THC-free CBD products
Recognizing the growing demand for CBD products without THC, Panacea Life Sciences and Chanelle McCoy Health have identified a specific target market. THC-free CBD products offer the benefits of CBD without the psychoactive effects of THC, making them appealing to a wide range of consumers. Through their partnership, they will focus on meeting the needs of this particular segment of the market.
Collaborating for an Ultra Pure CBD product
One of the exciting outcomes of this partnership is the collaboration to launch an Ultra Pure CBD product in the US. This product will be manufactured using a proprietary process that consistently produces CBD products with undetectable THC levels. By ensuring the highest purity standards, Panacea Life Sciences and Chanelle McCoy Health aim to set a new benchmark in CBD product quality and reliability.
Pureis®: Backed by safety clinical studies and FDA registered raw materials
Pureis®, the CBD brand by Chanelle McCoy Health, is the first CBD food supplement that is backed by safety clinical studies and FDA registered raw materials. This distinction sets Pureis® apart from other CBD products on the market and highlights the commitment of both companies to providing consumers with trusted and reliable CBD options.
Tapping into the growing global consumer market for CBD
In addition to their focus on the US market, Panacea Life Sciences and Chanelle McCoy Health have their sights set on the growing global consumer market for CBD. With the increasing awareness and acceptance of CBD around the world, this partnership positions both companies to expand their reach and offer their high-quality CBD products to a wider audience.
Entering the Brazilian cannabis market
As if the US market and global expansion weren’t enough, Panacea Life Sciences has recently made its foray into the Brazilian cannabis market. This exciting development comes as a result of a partnership with MyPharma2Go, further solidifying Panacea Life Sciences’ position as a key player in the CBD industry. With this strategic move, the partnership aims to tap into the potential of the Brazilian market and provide Brazilian consumers with top-quality CBD products.
In conclusion, the partnership between Panacea Life Sciences, Inc. and Chanelle McCoy Health is set to revolutionize the CBD industry in the US and beyond. With their shared values, commitment to safety and quality, and innovative approach, the alliance aims to become the premium provider of science-based CBD products. Consumers can look forward to the launch of the Ultra Pure CBD product, backed by rigorous clinical studies and manufactured to the highest standards. With their sights set on global expansion and the recent entry into the Brazilian cannabis market, Panacea Life Sciences and Chanelle McCoy Health are ready to make their mark on the growing CBD industry.